Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiographic trials of lipid-lowering therapy: end of an era?

× No keyword cloud information.

22 in total

Review 1. Atherosclerosis: inhibition of regression as therapeutic possibilities.

Authors: M J Davies; D M Krikler; D Katz
Journal: Br Heart J Date: 1991-06

2. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

Authors: J P Kane; M J Malloy; T A Ports; N R Phillips; J C Diehl; R J Havel
Journal: JAMA Date: 1990-12-19 Impact factor: 56.272

3. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Authors: L Cashin-Hemphill; W J Mack; J M Pogoda; M E Sanmarco; S P Azen; D H Blankenhorn
Journal: JAMA Date: 1990-12-19 Impact factor: 56.272

4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors: G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal: N Engl J Med Date: 1990-11-08 Impact factor: 91.245

5. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Authors: H Buchwald; R L Varco; J P Matts; J M Long; L L Fitch; G S Campbell; M B Pearce; A E Yellin; W A Edmiston; R D Smink
Journal: N Engl J Med Date: 1990-10-04 Impact factor: 91.245

6. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.

Authors: B F Stewart; B G Brown; X Q Zhao; L A Hillger; A D Sniderman; A Dowdy; L D Fisher; J J Albers
Journal: J Am Coll Cardiol Date: 1994-03-15 Impact factor: 24.094

7. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.

Authors: R M Krauss; F T Lindgren; P T Williams; S F Kelsey; J Brensike; K Vranizan; K M Detre; R I Levy
Journal: Lancet Date: 1987-07-11 Impact factor: 79.321

8. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Authors: J F Brensike; R I Levy; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini; D J Moriarty
Journal: Circulation Date: 1984-02 Impact factor: 29.690

9. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors: D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal: JAMA Date: 1987-06-19 Impact factor: 56.272

10. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors: D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal: Lancet Date: 1990-07-21 Impact factor: 79.321

1 in total

Review 1. A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.

Authors: Therese Heinonen; David D Waters; Peter Libby; Jean-Claude Tardif
Journal: Can J Cardiol Date: 2009-09 Impact factor: 5.223

1 in total